Form D · Other Health Care
Baylor Genetics Holdings, Inc.
Houston, TX · CIK 0002145246
Offering snapshot reported Jul 16, 2026 · SEC filing
- Reported sold
- $50M Offering amount: $100M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2026 | Initial | $49,999,986 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-591048
Total Amount Sold includes amounts paid in both cash and pursuant to conversion of indebtedness.
Source: Form D, filed Jul 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Berger | Executive |
| Xiangmin Cui | Director |
| Goki Ishikawa | Director |
| Joel Kaufman | Executive |
| Brendan Lee | Director |
| Kengo Takishima | Director, Executive |
| Victor Tong | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2450 Holcombe Blvd., Suite 2210
Houston, TX, 77021
Houston, TX, 77021